Treatment of the appropriate lithium or sodium 2,4-N,N'-disubstituted 1,3,5-triazapentadienate [RNC(R')NC(R')N(SiMe(3))M](2) (R = Ph, 2,6-(i)Pr(2)-C(6)H(3)(Dipp) or SiMe(3); R' = NMe(2) or 1-piperidino; M = Li or Na) with one or half equivalent portion of MgBr(2)(THF)(2) in Et(2)O under mild conditions furnishes in good yield the first structurally characterized molecular magnesium 2,4-N,N'-disubstituted 1,3,5-triazapentadienates [DippNC(NMe(2))NC(NMe(2))N(SiMe(3))MgBr](2) (1), [{RNC(R')NC(R')N(SiMe(3))}(2)Mg] (R = Ph, R' = NMe(2) 2; R = Ph, R' = 1-piperidino 3; R = SiMe(3), R' = 1-piperidino 4). The solid-state structure of 1 is dimeric and those of 2, 3, and 4 are monomeric. The ligand backbone NCNCN in 1 adopts a W-shaped configuration, while in 2, 3 and 4 adopts a U-shaped configuration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ic102401w | DOI Listing |
Inorg Chem
March 2011
Institute of Applied Chemistry, Shanxi University, Taiyuan 030006, People's Republic of China.
Treatment of the appropriate lithium or sodium 2,4-N,N'-disubstituted 1,3,5-triazapentadienate [RNC(R')NC(R')N(SiMe(3))M](2) (R = Ph, 2,6-(i)Pr(2)-C(6)H(3)(Dipp) or SiMe(3); R' = NMe(2) or 1-piperidino; M = Li or Na) with one or half equivalent portion of MgBr(2)(THF)(2) in Et(2)O under mild conditions furnishes in good yield the first structurally characterized molecular magnesium 2,4-N,N'-disubstituted 1,3,5-triazapentadienates [DippNC(NMe(2))NC(NMe(2))N(SiMe(3))MgBr](2) (1), [{RNC(R')NC(R')N(SiMe(3))}(2)Mg] (R = Ph, R' = NMe(2) 2; R = Ph, R' = 1-piperidino 3; R = SiMe(3), R' = 1-piperidino 4). The solid-state structure of 1 is dimeric and those of 2, 3, and 4 are monomeric. The ligand backbone NCNCN in 1 adopts a W-shaped configuration, while in 2, 3 and 4 adopts a U-shaped configuration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!